London, UK, December 3, 2018: Great Ormond Street Hospital Children’s Charity (GOSH Charity) and LifeArc, a leading UK medical research charity, today announce the launch of a new joint funding scheme: ‘Translational Research Accelerator Grants’ open primarily to research active health professionals at GOSH. Much of the research performed at GOSH and its dedicated research partner, the UCL Great Ormond Street Institute of Child Health (ICH) is focused on understanding rare diseases that affect children. This new grant scheme will support researchers to translate their findings into practical benefits for patients by delivering new therapeutics or diagnostics.
A total fund of £1 million is available and is expected to support several grants, each lasting up to three years. Collaborations with industry and other academic partners will also be encouraged. Funded projects will address a rare disease medical need, have a strong scientific rationale, credible delivery plan and have the potential to deliver clinical impact for the patient population at GOSH.
GOSH Charity and LifeArc will run workshops to provide further information and to assist candidates with their applications. The first workshop will be held in February 2019.
For more information about the Translational Research Accelerator Grants and the application process please click here.
Welcoming the scheme Dr Catriona Crombie, Philanthropic Fund manager, LifeArc, said;
“LifeArc’s main goal is to move innovative life science research further along its development path towards the patients who so desperately need effective treatments. LifeArc’s philanthropic activity has a particular focus on rare diseases. GOSH, with its unique patient population, wealth of expertise and aligned goals, is our ideal partner for this project.”
LifeArc is a medical research charity with over 25-years’ experience in helping scientists and organisations turn their research into effective diagnostics and treatments. LifeArc collaborates with a wide range of life science charities and other partners. In addition to early stage research funding, LifeArc also offers its partners expertise in; liaison with technology transfer offices, IP protection, diagnostics development, drug discovery, portfolio review, scientific scouting, campaigning, licensing opportunities, drug discovery pipeline, in vitro diagnostics and antibody engineering.
Glenn Mursell, Communications
Ruth Maurice, Communications
Tel: +44 (0) 2072393125
Notes to editors
LifeArc is a medical research charity with a 25-year legacy of helping scientists and organisations turn their research into treatments and diagnostics for patients. LifeArc is turning great science into greater patient impact. The charity brings together a network of partners to tackle specific diseases and directly funds academic and early stage research. So far, LifeArc’s work has helped to develop four drugs (Keytruda®, Actemra®, Tysabri® and Entyvio®) and a test for resistance to carbapenems. www.lifearc.org Twitter @lifearc1
Great Ormond Street Hospital Children’s Charity needs to raise money to support the hospital to give children who need help the most, the best chance for life. The charity funds research into pioneering new treatments for children, provides the most up to date medical equipment, funds support services for children and their families and supports the essential rebuilding and refurbishment of the hospital. You can help us to provide world class care for our patients and families. For more information visit www.gosh.org Twitter @GOSHCharity